{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:16:01Z","timestamp":1730520961355,"version":"3.28.0"},"reference-count":37,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,11,1]]},"DOI":"10.2169\/internalmedicine.1851-23","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T22:15:51Z","timestamp":1709504151000},"page":"2875-2884","source":"Crossref","is-referenced-by-count":1,"title":["Endoscopic and Histological Gastritis in University Students with &lt;i&gt;Helicobacter pylori&lt;\/i&gt; Infection"],"prefix":"10.2169","volume":"63","author":[{"given":"Shotaro","family":"Okanoue","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Sakae","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Obayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Iwamuro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Practical Gastrointestinal Endoscopy, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yanai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and <i>Helicobacter pylori<\/i>. vol. 61. International Agency for Research on Cancer, Lyon (FR), 1994: 1-241."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Parsonnet J, Friedman GD, Vandersteen DP, et al. <i>Helicobacter pylori<\/i> infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.","DOI":"10.1056\/NEJM199110173251603"},{"key":"3","unstructured":"3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-6740, 1992."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating <i>Helicobacter pylori<\/i> on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 100: 1037-1042, 2005.","DOI":"10.1111\/j.1572-0241.2005.41384.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takenaka R, Okada H, Kato J, et al. <i>Helicobacter pylori<\/i> eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 25: 805-812, 2007.","DOI":"10.1111\/j.1365-2036.2007.03268.x"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of <i>Helicobacter pylori<\/i> on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372: 392-397, 2008.","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. <i>Helicobacter pylori<\/i> eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348: g3174, 2014.","DOI":"10.1136\/bmj.g3174"},{"key":"8","unstructured":"8. Haruma K, Kato M, Inoue K, Murakami K, Kamada T. Kyoto Classification of Gastritis. 1st ed. Nihon Medical Center, Tokyo Japan, 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on <i>Helicobacter pylori<\/i>-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 94: 235-239, 2003.","DOI":"10.1111\/j.1349-7006.2003.tb01426.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Take S, Mizuno M, Ishiki K, et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after <i>Helicobacter pylori<\/i> eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 42 (Suppl 17): 21-27, 2007.","DOI":"10.1007\/s00535-006-1924-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yanaoka K, Oka M, Ohata H, et al. Eradication of <i>Helicobacter pylori<\/i> prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 125: 2697-2703, 2009.","DOI":"10.1002\/ijc.24591"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kakiuchi T, Matsuo M, Endo H, et al. A <i>Helicobacter pylori<\/i> screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 54: 699-707, 2019.","DOI":"10.1007\/s00535-019-01559-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Akamatsu T, Ichikawa S, Okudaira S, et al. Introduction of an examination and treatment for <i>Helicobacter pylori<\/i> infection in high school health screening. J Gastroenterol 46: 1353-1360, 2011.","DOI":"10.1007\/s00535-011-0450-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ichihara A, Ojima H, Goto K, et al. Serodiagnosis and bacterial genome of <i>Helicobacter pylori<\/i> infection. Toxins (Basel) 13: 467, 2021.","DOI":"10.3390\/toxins13070467"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Glupczynski Y, Labb\u00e9 M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of <i>Helicobacter pylori<\/i>. J Clin Microbiol 29: 2072-2075, 1991.","DOI":"10.1128\/jcm.29.9.2072-2075.1991"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cederbrant G, Kahlmeter G, Ljungh A. The E test for antimicrobial susceptibility testing of <i>Helicobacter pylori<\/i>. J Antimicrob Chemother 31: 65-71, 1993.","DOI":"10.1093\/jac\/31.1.65"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1: 87-97, 1969.","DOI":"10.1055\/s-0028-1098086"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.","DOI":"10.1097\/00000478-199610000-00001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kato S, Nakajima S, Nishino Y, et al. Association between gastric atrophy and <i>Helicobacter pylori<\/i> infection in Japanese children: a retrospective multicenter study. Dig Dis Sci 51: 99-104, 2006.","DOI":"10.1007\/s10620-006-3091-5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Hojo M, Nagahara A, Kudo T, et al. Endoscopic findings of <i>Helicobacter pylori<\/i> gastritis in children and young adults based on the Kyoto classification of gastritis and age-associated changes. JGH Open 5: 1197-1202, 2021.","DOI":"10.1002\/jgh3.12652"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kiga K, Mimuro H, Suzuki M, et al. Epigenetic silencing of <i>miR-210<\/i> increases the proliferation of gastric epithelium during chronic <i>Helicobacter pylori<\/i> infection. Nat Commun 5: 4497, 2014.","DOI":"10.1038\/ncomms5497"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Petkevicius V, Streleckiene G, Balciute K, et al. Association of long non-coding RNA polymorphisms with gastric cancer and atrophic gastritis. Genes (Basel) 11: 1505, 2020.","DOI":"10.3390\/genes11121505"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Fujii Y, Yoshihashi K, Suzuki H, et al. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc Natl Acad Sci U S A 109: 20584-20589, 2012.","DOI":"10.1073\/pnas.1208651109"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Samloff IM. Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 61: 185-188, 1971.","DOI":"10.1016\/S0016-5085(19)33596-6"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Samloff IM, Liebman WM. Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 65: 36-42, 1973.","DOI":"10.1016\/S0016-5085(19)33138-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98: 735-739, 2003.","DOI":"10.1111\/j.1572-0241.2003.07410.x"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44: 693-697, 1999.","DOI":"10.1136\/gut.44.5.693"},{"key":"28","unstructured":"28. Paik CN, Chung IS, Nam KW, et al. Relationship between pepsinogen I\/II ratio and age or upper gastrointestinal diseases in <i>Helicobacter pylori<\/i>-positive and -negative subjects. Korean J Gastroenterol 50: 84-91, 2007 (in Korean, abstracted in English)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Konno M, Fujii N, Yokota S, et al. Five-Year Follow-Up Study of Mother-to-Child Transmission of <i>Helicobacter pylori<\/i> Infection Detected by a Random Amplified Polymorphic DNA Fingerprinting Method. J Clin Microbiol 43: 2246-2250, 2005.","DOI":"10.1128\/JCM.43.5.2246-2250.2005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ito M, Haruma K, Kamada T, et al. <i>Helicobacter pylori<\/i> eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 16: 1449-1456, 2002.","DOI":"10.1046\/j.1365-2036.2002.01311.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of <i>Helicobacter pylori<\/i> infection: a community-based study of gastric cancer prevention. Gut 62: 676-682, 2013.","DOI":"10.1136\/gutjnl-2012-302240"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kato M, Terao S, Adachi K, et al. Changes in endoscopic findings of gastritis after cure of <i>H. pylori<\/i> infection: multicenter prospective trial. Dig Endosc 25: 264-273, 2013.","DOI":"10.1111\/j.1443-1661.2012.01385.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kodama M, Murakami K, Okimoto T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after <i>Helicobacter pylori<\/i> eradication. J Gastroenterol 47: 394-403, 2012.","DOI":"10.1007\/s00535-011-0504-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Kono Y, Kanzaki H, Tsuzuki T, et al. A multicenter observational study on the clinicopathological features of gastric cancer in young patients. J Gastroenterol 54: 419-426, 2019.","DOI":"10.1007\/s00535-018-1525-4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kusano C, Gotoda T, Suzuki S, Ikehara H, Moriyama M. Safety of first-line triple therapy with a potassium-competitive acid blocker for <i>Helicobacter pylori<\/i> eradication in children. J Gastroenterol 53: 718-724, 2018.","DOI":"10.1007\/s00535-017-1406-2"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Okuda M, Kikuchi S, Mabe K, et al. Nationwide survey of <i>Helicobacter pylori<\/i> treatment for children and adolescents in Japan. Pediatr Int 59: 57-61, 2017.","DOI":"10.1111\/ped.13038"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for <i>Helicobacter pylori<\/i> eradication in children: a randomized trial. Gastroenterology 129: 1414-1419, 2005.","DOI":"10.1053\/j.gastro.2005.09.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_1851-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T03:30:52Z","timestamp":1730518252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/21\/63_1851-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":37,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1851-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"1851-23"}}